A number of other research firms have also recently weighed in on CATS. Zacks Investment Research cut Catasys from a buy rating to a hold rating in a research note on Monday, July 29th. Dougherty & Co began coverage on Catasys in a research note on Tuesday, May 7th. They issued a buy rating on the stock. Finally, Canaccord Genuity upped their price objective on Catasys from $15.00 to $26.00 and gave the company a buy rating in a report on Friday, May 10th. Two equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $18.80.
CATS opened at $15.70 on Thursday. Catasys has a 1-year low of $7.51 and a 1-year high of $20.83. The stock’s fifty day simple moving average is $17.82 and its 200 day simple moving average is $15.40. The stock has a market cap of $255.65 million, a PE ratio of -17.64 and a beta of 1.61.
A number of hedge funds and other institutional investors have recently modified their holdings of CATS. Invesco Ltd. boosted its holdings in shares of Catasys by 26.3% in the 2nd quarter. Invesco Ltd. now owns 109,157 shares of the company’s stock worth $2,098,000 after purchasing an additional 22,728 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Catasys by 43.9% in the 2nd quarter. Vanguard Group Inc. now owns 389,307 shares of the company’s stock worth $7,482,000 after purchasing an additional 118,792 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Catasys by 3,667.0% in the 2nd quarter. BlackRock Inc. now owns 460,664 shares of the company’s stock worth $8,855,000 after purchasing an additional 448,435 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Catasys by 88.7% in the 2nd quarter. Northern Trust Corp now owns 37,249 shares of the company’s stock worth $716,000 after purchasing an additional 17,507 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Catasys in the 2nd quarter worth about $302,000. 13.31% of the stock is currently owned by hedge funds and other institutional investors.
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Featured Story: What is a CD ladder?
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.